Diving Deep into Personalized CTV Advertising with Swoop and Roku

Featured Image

 

Connected television (CTV) remains one of the fastest growing and most effective channels for pharmaceutical marketers to engage with their core customers. According to eMarketer, CTV is the most rapidly expanding ad channel in the US and is projected to grow 22.4%, reaching a total of $30.10 billion in 2024. Through privacy safe advanced targeting technology, high-value streaming inventory and the increased use of personalization, brands can better find and activate ideal DTC and HCP audiences at all phases of the diagnosis and treatment journey while consuming their preferred content.

During this conversation with leaders from Roku and Swoop, hear how the CTV landscape is changing, the advantages it gives pharma marketers and practical use cases that can be applied across your own advertising. 

 

Why MyHealthTeam Became a Swoop Company and What It Means for You

By Eric Peacock, Co-founder and President of MyHealthTeam, a Swoop company

After Swoop acquired MyHealthTeam last month, one of our clients - an...

Read More

Precision over quantity: How Swoop, CMI Media Group, and Genentech unlocked qualified patient reach on Meta

Background

In the ever-evolving landscape of digital healthcare marketing, reaching the right patients with the right message at the right time is...

Read More

Swoop Expands Patient-Centric Engagement with Acquisition of MyHealthTeam, a Leading Opted-In Patient Community in the U.S.

NEW YORK, January 7, 2025 — Swoop, an industry leader in AI-driven, data-powered omnichannel healthcare marketing, today announced its acquisition of

Read More